CAV1 and prostate neoplasm: Nevertheless, the accelerated growth of untreated prostate tumors in the Cav1-deficient background hinted to a potential risk of treatment strategies targeting endothelial Cav1 for radiosensitization in these tumors making careful validation of such treatment strategies with respect to adverse growth promoting effects absolutely necessary19.